Clinical trial
Prospective Cross Sectional Study To Assess The Clinical Utility of Optical Coherence Tomography to Measure Axonal Degeneration of the Optic Nerve, in a Cohort of 200 Subjects Meeting the Diagnostics Criteria of Multiple Sclerosis
NCT03313843 is registered in ClinicalTrials.gov with Tampa Bay Uveitis Center, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cross Sectional Study To Assess The Clinical Utility of Optical Coherence Tomography to Measure Axonal Degeneration of the Optic Nerve, in a Cohort of 200 Subjects Meeting the Diagnostics Criteria of Multiple Sclerosis
- Lead sponsor
- Tampa Bay Uveitis Center, LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 9, 2018
- Completion date
- April 30, 2021
- Enrollment
- 73 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.